Rigel Pharmaceuticals Inc (RIGL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
899,996,000
EV to revenue ratio (TTM)
3.095
EV to ebitda
9.11
Financial Performance
Revenue (TTM)
276,785,000
Gross profit (TTM)
209,271,000
EBITDA
89,699,000
Profitability
Operating margin (TTM)
29.90%
Profit margin
116.30%
Return on assets (TTM)
14.90%
Return on equity (TTM)
126.90%
Per Share Metrics
Revenue per share (TTM)
15.12
EPS
16.89
Diluted EPS (TTM)
16.89
Book value
22.81
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
2.853
Trailing P/E
2.853
Forward P/E
9.29
PEG ratio
-0.1
Price to sales ratio (TTM)
3.221
Price to book ratio (TTM)
2.144
Growth
Quarterly earnings growth (YoY)
-22.60%
Quarterly revenue growth (YoY)
-73.20%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.198